Navigation Links
Carreras Foundation to Endow Clinical-Research Chair at Fred Hutchinson Cancer Research Center
Date:10/16/2007

Internationally renowned tenor expresses gratitude for successful treatment

SEATTLE, Oct. 16 /PRNewswire/ -- The Friends of Jose Carreras International Leukemia Foundation has announced it will endow a chair for clinical research at Fred Hutchinson Cancer Research Center in honor of E. Donnall Thomas, M.D., who pioneered the bone-marrow transplant.

The Foundation cites a strong wish to honor Carreras and Thomas, emeritus director of clinical research at the Hutchinson Center. Thomas' research in bone-marrow transplantation has saved thousands of lives and won the 1990 Nobel Prize in physiology or medicine.

In 1987, Carreras was diagnosed with acute lymphoblastic leukemia and traveled to the Hutchinson Center for what proved to be a successful series of treatments, including a bone-marrow transplant. In 1988, in deep gratitude to both science and society for the life-saving treatment and the care and affection he received during his illness, Carreras enlisted the help of noted physicians and scientists to initiate the Fundacion Internacional Josep Carreras in his hometown of Barcelona.

"I want to express my deepest admiration for the work of the Fred Hutchinson Cancer Research Center and its dedication toward science, leukemia patients and their families," Carreras said. "The Hutchinson Center and the Foundation share a common goal: to achieve that leukemia becomes one day a totally curable disease, always and for everyone. It is a real pleasure to collaborate with the Fred Hutchinson Cancer Research Center, and especially with an admirable person like Dr. Thomas."

"There are innumerable links that bind me with the Fred Hutchinson Cancer Research Center and with Dr. Thomas. It is an honor and a great responsibility to continuously count on the trust, help and support of the Hutchinson Center and Dr. Thomas," Carreras said.

The Spanish Carreras foundation and branch foundations in the United States, Germany and Switzerland concentrate their efforts in four main areas: funding scientific research, health care infrastructure, promotion of transplantation, and social service to leukemia patients and their families. In addition to funding leukemia research, the Spanish Carreras foundation has worked to establish a bone-marrow registry in Spain. The foundation and its affiliates have helped support dozens of scientists worldwide, including annual fellowships for promising early-career scientists at the Center and throughout the world.

The Jose Carreras/E. Donnall Thomas Endowed Chair for Cancer Research will be awarded to a full member of the Center's Clinical Research Division who spends at least 75 percent of his/her time in research. Candidates will be nominated by their peers and selected by a committee chaired by the Center's president and director. They must have an international reputation for excellence in their field of research and, in addition, will have independent grant support.

In September, Thomas and Center colleagues celebrated the 50th anniversary of his groundbreaking paper on the promise of human bone-marrow transplantation in the New England Journal of Medicine.

At Fred Hutchinson Cancer Research Center, our interdisciplinary teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Our researchers, including three Nobel laureates, bring a relentless pursuit and passion for health, knowledge and hope to their work and to the world. For more information, please visit http://www.fhcrc.org.

CONTACT

Christi Ball Loso

(206) 667-5215

closo@fhcrc.org


'/>"/>
SOURCE Fred Hutchinson Cancer Research Center
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Woodruff Foundation Grant To Support Doctorate Of Nursing Practice Program
2. Kalam To Lay Foundation Of Vellore Research Center
3. Nippon Foundation To Help Leprosy Patients
4. Parents Launch SV40 Cancer Foundation In Memory of Son
5. Cancer Aid And Research Foundation: Offering Endless Hope To Cancer Patients
6. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
7. PM Launches Healthcare Foundation For India
8. Prime Minister Manmohan Singh, Flags Off Public Health Foundation of India
9. Gates Foundation to donate USD 104 million to TB Alliance
10. MoU for HIV/AIDS Signed by Nigeria and Clinton Foundation
11. Gates Foundation Adopts Fight against Encephalitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated ... in breathing. Oral appliances can offer significant relief to about 75 percent of ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... the introduction of an innovative new design of the shoulder pad. The shoulder ... maximum comfort while controlling your pain while using cold therapy. By utilizing ice and ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: , ... to enable prevention of a major side effect of chemotherapy in children. Cisplatin ... patients. For cisplatin, hearing loss is FDA listed on-label as a dose limiting ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s ... the 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017 The Rebound mobile ... the struggle to reverse the tide of prescription drug addiction. ... regulating their medicine intake and stepping down their dosage in ... to launch in December 2017; the first 100,000 people to ... more at http://www.rebound-solution.com/ ...
(Date:9/27/2017)... , Sept. 27, 2017  Commended for their devotion to ... awards. Ranked as number one in the South Florida Business ... in Inc. 5000 yearly list, the national specialty pharmacy has ... Armando Bardisa will soon be honored by SFBJ as ... Set to receive his award in October, ...
(Date:9/25/2017)... Sept. 25, 2017  EpiVax, Inc., a leader ... and immune-engineering today announced the launch of EpiVax ... of personalized therapeutic cancer vaccines. EpiVax has provided ... access to enabling technologies to the new precision ... lead EpiVax Oncology as Chief Executive Officer. Gad ...
Breaking Medicine Technology: